Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) traded down 3.1% during trading on Monday . The stock traded as low as $1.87 and last traded at $1.87. 11,400 shares traded hands during mid-day trading, an increase of 143% from the average session volume of 4,692 shares. The stock had previously closed at $1.93.
Covalon Technologies Trading Down 1.1%
The company's 50 day moving average price is $1.83 and its 200-day moving average price is $1.84. The company has a market capitalization of $49.63 million, a PE ratio of 20.11 and a beta of 0.54.
Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported $0.01 EPS for the quarter, hitting analysts' consensus estimates of $0.01. Covalon Technologies had a net margin of 10.95% and a return on equity of 13.40%. The firm had revenue of $5.27 million for the quarter, compared to analyst estimates of $7.67 million.
About Covalon Technologies
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Featured Articles
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access